The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: a prospective study of women diagnosed with GDM during a period of universal GDM screening.
Delia BogdanetMichelle Toth CastilloHelen DohenyLouise DervanMiguel Angel Luque-FernandezJose HalperinPaula M O'SheaFidelma P DunnePublished in: Diabetic medicine : a journal of the British Diabetic Association (2023)
Our study found that PP pGCD9 may be a promising biomarker to identify women not requiring PP glucose intolerance screening using the traditional OGTT. While the diagnostic accuracy of pGCD59 is good, fasting plasma glucose remains a better test for the identification of PP glucose intolerance.